R&D to Revenue
41.91%
Fiscal year · Period ending:

GMAB R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
GMAB r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 41.9086% | −3.38 pts | |
| 45.2848% | −1.03 pts | |
| 46.3154% | +7.97 pts | |
| 38.3454% | −10.95 pts | |
| 49.2926% | +18.27 pts | |
| 31.0256% | −13.44 pts | |
| 44.4652% | −2.84 pts | |
| 47.3089% | +10.35 pts | |
| 36.9605% | +0.57 pts | |
| 36.3894% | −6.65 pts | |
| 43.0396% | −16.43 pts | |
| 59.4647% | −20.04 pts | |
| 79.5057% | −31.24 pts | |
| 110.7433% | −41.00 pts | |
| 151.7391% | +54.53 pts | |
| 97.2114% | −62.39 pts | |
| 159.5972% | −20.61 pts | |
| 180.203% | +63.40 pts | |
| 116.8007% | −148.76 pts | |
| 265.5559% | −43.16 pts | |
| 308.7183% | −8,794.67 pts | |
| 9,103.3894% | +8,597.02 pts | |
| 506.3709% | +506.37 pts | |
| 0% | — |
Frequently asked questions: GMAB r&d to revenue
What is Genmab A/S (GMAB)'s current r&d to revenue?
Genmab A/S (GMAB)'s latest reported r&d to revenue (Fiscal year) is 41.91% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for GMAB?
Stock Alarm Pro provides 24 dated annual fiscal periods observations for Genmab A/S (GMAB)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GMAB's r&d to revenue to peers or set an alert?
You can open GMAB's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GMAB delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance